Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo BioSciences Inc (NASDAQ:SGMO)

2.95
Delayed Data
As of 3:59pm ET
 -0.05 / -1.67%
Today’s Change
2.80
Today|||52-Week Range
9.91
-67.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$211.9M

Company Description

Sangamo BioSciences, Inc. researches and develops transcription factors in the regulation of genesoperates. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Lanphier O. Edward II on June 22, 1995 and is headquartered in Richmond, CA.

Contact Information

Sangamo BioSciences, Inc.
Point Richmond Tech Center II
Richmond California 94804
P:(510) 970-6000
Investor Relations:
15109706000271

Employees

Shareholders

Individual stakeholders9.04%
Other institutional37.87%
Mutual fund holders25.48%

Top Executives

Alexander MacraePresident, Chief Executive Officer & Director
Henry Ward WolffChief Financial Officer & Executive Vice President
Dale G. AndoChief Medical Officer & VP-Therapeutic Development
Edward J. RebarVice President-Technology
Mohammad A. El-KalayVice President-Technical Operations